Literature DB >> 31197232

The autonomic nervous system and cardiac arrhythmias: current concepts and emerging therapies.

Neil Herring1,2, Manish Kalla3, David J Paterson4.   

Abstract

Research into cardiac autonomic control has received great interest in the past 20 years, and we are now at a critical juncture with regard to the clinical translation of the experimental findings. A rush to develop clinical interventions and implant a range of devices aimed at cardiac neuromodulation therapy has occurred. This interest has been driven by research, superimposed on commercial opportunities and perhaps the more relaxed regulatory framework governing implantable devices and interventions compared with that for pharmacotherapy. However, many of the results of the clinical trials into these therapies have been disappointing or conflicting. This lack of positive results is partly attributable to a scramble to find simple solutions for complex problems that we do not yet fully understand. Are there reasons to be optimistic? In this Review, we highlight areas in the field of cardiac autonomic control that we feel show the most promise for clinical translation and areas in which our current range of blunt tools need to be refined to bring about long-term success in treating arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31197232     DOI: 10.1038/s41569-019-0221-2

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  38 in total

Review 1.  The Property-Based Practical Applications and Solutions of Genetically Encoded Acetylcholine and Monoamine Sensors.

Authors:  Jun Chen; Katriel E Cho; Daria Skwarzynska; Shaylyn Clancy; Nicholas J Conley; Sarah M Clinton; Xiaokun Li; Li Lin; J Julius Zhu
Journal:  J Neurosci       Date:  2021-02-24       Impact factor: 6.167

2.  Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.

Authors:  Jonathan D Hoang; Siamak Salavatian; Naoko Yamaguchi; Mohammed Amer Swid; Hamon David; Marmar Vaseghi
Journal:  JCI Insight       Date:  2020-06-04

3.  Metabolism regulator adiponectin prevents cardiac remodeling and ventricular arrhythmias via sympathetic modulation in a myocardial infarction model.

Authors:  Zhen Zhou; Chengzhe Liu; Saiting Xu; Jun Wang; Fuding Guo; Shoupeng Duan; Qiang Deng; Ji Sun; Fu Yu; Yuyang Zhou; Meng Wang; Yueyi Wang; Liping Zhou; Hong Jiang; Lilei Yu
Journal:  Basic Res Cardiol       Date:  2022-07-11       Impact factor: 12.416

4.  Neutrophils incite and macrophages avert electrical storm after myocardial infarction.

Authors:  Jana Grune; Andrew J M Lewis; Masahiro Yamazoe; Maarten Hulsmans; David Rohde; Ling Xiao; Shuang Zhang; Christiane Ott; David M Calcagno; Yirong Zhou; Kerstin Timm; Mayooran Shanmuganathan; Fadi E Pulous; Maximilian J Schloss; Brody H Foy; Diane Capen; Claudio Vinegoni; Gregory R Wojtkiewicz; Yoshiko Iwamoto; Tilman Grune; Dennis Brown; John Higgins; Vanessa M Ferreira; Neil Herring; Keith M Channon; Stefan Neubauer; David E Sosnovik; David J Milan; Filip K Swirski; Kevin R King; Aaron D Aguirre; Patrick T Ellinor; Matthias Nahrendorf
Journal:  Nat Cardiovasc Res       Date:  2022-07-11

Review 5.  The Mechanism of Cardiac Sympathetic Activity Assessment Methods: Current Knowledge.

Authors:  Jiakun Li; Lihui Zheng
Journal:  Front Cardiovasc Med       Date:  2022-06-23

6.  Post-Ganglionic Sympathetic Neurons can Directly Sense Raised Extracellular Na+ via SCN7a/Nax.

Authors:  Harvey Davis; David J Paterson; Neil Herring
Journal:  Front Physiol       Date:  2022-06-17       Impact factor: 4.755

7.  Abnormal Cyclic Nucleotide Signaling at the Outer Mitochondrial Membrane In Sympathetic Neurons During the Early Stages of Hypertension.

Authors:  Dan Li; Kun Liu; Harvey Davis; Calum Robertson; Oliver C Neely; Adib Tarafdar; Ni Li; Konstantinos Lefkimmiatis; Manuela Zaccolo; David J Paterson
Journal:  Hypertension       Date:  2022-05-04       Impact factor: 9.897

8.  Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target.

Authors:  Xin Zhang; Can Hu; Hai-Ming Wu; Zhen-Guo Ma; Qi-Zhu Tang
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

9.  The Heart's Little Brain: Shedding New Light and CLARITY on the "Black Box".

Authors:  Neil Herring; David J Paterson
Journal:  Circ Res       Date:  2021-04-29       Impact factor: 17.367

10.  Sinoatrial node pacemaker cells: cardiomyocyte- or neuron-like cells?

Authors:  Bin Zhou
Journal:  Protein Cell       Date:  2021-02-06       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.